Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Screening

Our bioscientists work closely with you and your Chemistry, Computational Chemistry and DMPK teams to deliver carefully tailored, informative and efficient screening programs using state of the art equipment, to deliver fully characterised hit, lead and candidate series.

Our scientists can support your project through the provision of reliable, flexible and robust Iterative screening to accelerate your Design-make-test-analyse cycle. In addition, we can undertake tailored Mechanism of Action (MOA) studies to provide a deep understanding of your compounds engagement with the target to inform your compound progression and design strategies.

Screening Services

Screening Cascade Development

When designing tailored, streamlined and informative screening cascades our scientists have the experience to ensure the continual delivery of high quality, reliable data throughout the lifetime of your project.

DISCOVER

Medium and High Throughput Screening

Sygnature’s scientists are experts at designing bespoke hit finding solutions, with tailored screening approaches.

DISCOVER

Iterative Screening

Design-Make-Test-Analyse cycles to expedite the progression of your project through the discovery pipeline.

DISCOVER

Mechanism of Action (MOA)

Sygnature Discovery is expert at applying different, complementary approaches that can be taken to identify compound MOA.

DISCOVER

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form